Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs

Jacqueline M Plemons; Ibtisam Al-Hashimi; Cindy L Marek

doi:10.14219/jada.2014.44

Back

Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs

Journal article

Peer reviewed

Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs

Jacqueline M Plemons, Ibtisam Al-Hashimi and Cindy L Marek

The Journal of the American Dental Association (1939), Vol.145(8), pp.867-873

08/2014

DOI: 10.14219/jada.2014.44

PMID: 25082939

View Online

Abstract

Xerostomia, also known as "dry mouth," is a common but frequently overlooked condition that is typically associated with salivary gland hypofunction, which is the objective measurement of reduced salivary flow. Patients with dry mouth exhibit symptoms of variable severity that are commonly attributed to medication use, chronic disease and medical treatment, such as radiotherapy to the head and neck region. Chronic xerostomia significantly increases the risk of experiencing dental caries, demineralization, tooth sensitivity, candidiasis and other oral diseases that may affect quality of life negatively. This article presents a multidisciplinary approach to the clinical management of xerostomia, consistent with the findings of published systematic reviews on this key clinical issue. Initial evaluation of patients with dry mouth should include a detailed health history to facilitate early detection and identify underlying causes. Comprehensive evaluation, diagnostic testing and periodic assessment of salivary flow, followed by corrective actions, may help prevent significant oral disease. A systematic approach to xerostomia management can facilitate interdisciplinary patient care, including collaboration with physicians regarding systemic conditions and medication use. Comprehensive management of xerostomia and hyposalivation should emphasize patient education and lifestyle modifications. It also should focus on various palliative and preventive measures, including pharmacological treatment with salivary stimulants, topical fluoride interventions and the use of sugar-free chewing gum to relieve dry-mouth symptoms and improve the patient's quality of life.

United States

Humans

Salivary Glands - physiopathology

Xerostomia - complications

Xerostomia - therapy

American Dental Association

Xerostomia - chemically induced

Details

Title: Subtitle: Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs
Creators: Jacqueline M Plemons - Dr. Plemons is a professor, Department of Periodontics, Texas A&M University Baylor College of Dentistry, Dallas
Ibtisam Al-Hashimi - Dr. Al-Hashimi is a professor and the director, Salivary Dysfunction Clinic and Stomatology Research Laboratory, Department of Periodontics, Texas A&M University Baylor College of Dentistry, Dallas
Cindy L Marek - Dr. Marek is an associate professor, Department of Oral Pathology, Radiology and Medicine, College of Dentistry, The University of Iowa, Iowa City. Address correspondence to the American Dental Association Council on Scientific Affairs, 211 E. Chicago Ave., Chicago, Ill. 60611, e-mail science@ada.org
Resource Type: Journal article
Publication Details: The Journal of the American Dental Association (1939), Vol.145(8), pp.867-873
DOI: 10.14219/jada.2014.44
PMID: 25082939
NLM abbreviation: J Am Dent Assoc
ISSN: 0002-8177
eISSN: 1943-4723
Publisher: American Dental Association; England
Language: English
Date published: 08/2014
Academic Unit: Oral Pathology, Radiology and Medicine; Pharmacy Practice and Science
Record Identifier: 9984065501402771

Metrics

59 Record Views

136 Times Cited - Web of Science

See more details